Target
Androgen Receptors
9 abstracts
Abstract
Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.Org: MD Anderson Cancer Center, University of Chicago, University of Miami Health System, Tom Baker Cancer Centre, Emory University, Atlanta, GA, USA,
Abstract
Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data.Org: MetroHealth Medical Center, Case Western Reserve University School of Medicine, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Seidman Cancer Center, Johns Hopkins University - School of Medicine,
Abstract
Cost-effectiveness analysis (CEA) of seven treatment regimens in metastatic hormone-sensitive prostate cancer (mHSPC): A public payer perspective using network meta-analysis.Org: Huntsman Cancer Institute at the University of Utah, University of Utah, Case Western Reserve University School of Medicine, University of Utah/Huntsman Cancer Institute,
Abstract
Nutrition assessment reports in oncology clinical trials.Org: Department of Supportive Oncology, Levine Cancer Institute, Atrium Health Carolinas Medical Center, Department of Internal Medicine at Atrium Health Carolinas Medical Center, Department of Solid Tumor Oncology and Supportive Oncology,
Abstract
Baseline endogenous serum testosterone levels and all-cause mortality in men with prostate cancer treated by radical radiotherapy: 11-year follow-up data.Org: Nottingham University Hospitals NHS Trust, St Bartholomew's Hospital, Nottingham University Hospital NHS Trust, Royal United Hospitals Bath NHS Foundation Trust, University of Nottingham,
Abstract
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.Org: Ohio State University Wexner Medical Center, Columbus, OH, Yale School of Medicine, Madison, CT, The Ohio State University Wexner Medical Center,
Abstract
Real-world evidence analysis of early-stage prostate cancer using natural language processing.Org: Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital/VHIO, University Hospital La Fe, SERVICIO DE ONCOLOGIA MEDICA, Hospital de la Santa Creu i Sant Pau,
Abstract
Navigating how to choose an oncologist as part of the cancer journey.Org: CVS Health, Lincoln, RI,
Abstract
External validation of biomechanical computed tomography for fracture risk classification in metastatic hormone sensitive prostate cancer.Org: MD Anderson Cancer Center, University of Pennsylvania School of Medicine, University of Pennsylvania, O.N. Diagnostics, University of California, Berkeley,